IRIS
COSTANZO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.254
EU - Europa 1.436
AS - Asia 935
AF - Africa 225
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 12
Totale 10.891
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.194
SG - Singapore 433
CN - Cina 376
FI - Finlandia 369
IE - Irlanda 319
NG - Nigeria 223
DE - Germania 148
FR - Francia 141
IT - Italia 109
NL - Olanda 94
GB - Regno Unito 65
SE - Svezia 55
CA - Canada 53
BE - Belgio 43
IN - India 38
TR - Turchia 28
IL - Israele 23
RU - Federazione Russa 18
CZ - Repubblica Ceca 13
A2 - ???statistics.table.value.countryCode.A2??? 11
UA - Ucraina 11
AU - Australia 9
RO - Romania 9
CL - Cile 7
ES - Italia 7
MX - Messico 7
HK - Hong Kong 6
KR - Corea 6
NZ - Nuova Zelanda 6
JO - Giordania 5
JP - Giappone 5
DK - Danimarca 4
IR - Iran 4
MD - Moldavia 4
RS - Serbia 4
BG - Bulgaria 3
BR - Brasile 3
CH - Svizzera 3
EU - Europa 3
GR - Grecia 3
NO - Norvegia 3
PT - Portogallo 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
PL - Polonia 2
BD - Bangladesh 1
EC - Ecuador 1
EG - Egitto 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
IQ - Iraq 1
KW - Kuwait 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MY - Malesia 1
PE - Perù 1
TH - Thailandia 1
TN - Tunisia 1
Totale 10.891
Salva come PNG Salva come JPEG
Città #
Chandler 1.695
Wilmington 1.445
San Mateo 575
Ann Arbor 453
Helsinki 369
Shanghai 360
Boardman 339
Ashburn 338
Dublin 319
Singapore 290
Lawrence 261
Princeton 261
Leawood 259
Benin City 223
New York 187
Fairfield 146
Woodbridge 131
Paris 126
Amsterdam 84
London 57
Toronto 43
San Diego 41
Seattle 41
Brussels 40
Falls Church 33
Milan 32
Phoenix 32
Los Angeles 29
Kocaeli 28
Norwalk 24
Santa Clara 23
Houston 19
Redmond 16
Falkenstein 12
Brno 11
Moscow 11
Dallas 10
Chennai 9
Des Moines 9
Dronten 8
Duncan 8
Abbiategrasso 7
Hanover 7
Cambridge 6
Florence 6
Monmouth Junction 6
Newark 6
Pune 6
Redwood City 6
Amman 5
Clearwater 5
Andover 4
Chicago 4
Chisinau 4
Esbjerg 4
Genoa 4
Rome 4
Tokyo 4
Aguascalientes 3
Auckland 3
Bergamo 3
Berlin 3
Catania 3
Collegeville 3
Dunedin 3
Frankfurt am Main 3
Henderson 3
Kemerovo 3
Monterrey 3
Munich 3
Ottawa 3
Pavia 3
San Francisco 3
Taipei 3
Tappahannock 3
Winnipeg 3
Apo 2
Athens 2
Beijing 2
Chengdu 2
Chieti 2
Cosenza 2
Gunzenhausen 2
Gwanak-gu 2
Hangzhou 2
Kochi 2
Las Vegas 2
Logan 2
Longueville 2
Ludhiana 2
Nancy 2
Naples 2
Olomouc 2
Sacramento 2
Santa Coloma de Gramenet 2
Smederevo 2
Spoltore 2
Susquehanna 2
São Paulo 2
Thyez 2
Totale 8.587
Salva come PNG Salva come JPEG
Nome #
Living with Chronic Spontaneous Urticaria in Italy: A Narrative Medicine Project to Improve the Pathway of Patient Care 299
CD28 costimulation regulates FOXP3 in a RelA/NF-κB-dependent mechanism. 116
y Clinical similarity of the biosimilar ABP 501 compared with adalimumab after single transition: long-term results from a randomized controlled, double-blind, 52-week, phase III trial in patients with moderate-to-severe plaque psoriasis 84
Rosacea-like Acute Reaction After Hyaluronic Acid Dermal Filler 83
Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes. 67
IL-21 in the pathogenesis and treatment of skin diseases. 65
Herpes simplex virus disrupts NF-kappa B regulation by blocking its recruitment on the I kappa B alpha promoter and directing the factor on viral genes 64
Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis 61
Actinic keratosis treated with an immune response modifier: a case report of six patients 60
FGF8, c-Abl and p300 participate in a pathway that controls stability and function of the Delta Np63 alpha protein 60
How to make a skin-tight dress: the p63/claudin-1 connection 58
Noninferiority of biosimilar MSB110222 to reference adalimumab for chronic plaque psoriasis 57
Brodalumab: a new way to inhibit IL-17 in psoriasis 57
p63 induces key target genes required for epidermal morphogenesis 56
Zosteriform metastasis of occult bronchogenic carcinoma. 56
Topical use of valproic acid for the prevention or treatment of skin disorders 56
Specific Infiltrate of Hodgkin Lymphoma at Site of Cellulitis Mimicking Secondary Cutaneous Involvement 56
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappa B subunits on IL-8 and Bcl-xL gene promotors 55
Keratosis punctata palmoplantaris and malignancies: Case report 55
'Living with chronic urticaria': a study through narrative medicine to improve the quality of care 55
Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta 55
Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics 55
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis 54
Psoriasis: from pathogenesis to novel therapeutic approaches. 54
A p38-dependent pathway regulates DNp63 DNA binding to p53 dependent promoters in UV-induced apoptosis of keratinocytes 54
High-dose intravenous immunoglobulin for severe drug reactions: Efficacy in toxic epidermal necrolysis 54
The p53/p63/p73 family of transcription factors: overlapping and distinct functions. . 2000 May;113 ( Pt 10):1661-70 53
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 53
A feedback regulatory loop between p63 and Dlx3: implications for epidermal differentiation 53
Psychiatric comorbidity and suicidal ideation in psoriasis, melanoma and allergic disorders 53
Biomarkers to optimize ustekinumab therapy in psoriatic patients 52
Ashy dermatosis: clinico-pathological associations in two cases] 52
Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study 51
Safety and efficacy study on etanercept in patients with plaque psoriasis 51
Histone deacetylases as new therapeutical targets for the treatment of Non-Melanoma Skin Cancer: results of phase I/IIa trial with topical DAC060 51
A role for the p63-IKKalpha pathway in the development of ectodermal dysplasias 51
Treatment of psoriasis and psoriatic arthritis. 50
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 50
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody. 50
Clinical applications of methyl aminolevulinate photodynamic therapy (MAL-PDT) for the treatment of non melanoma-skin cancers 50
Role of p63 in keratinocyte differentiation and proliferation 50
Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway 50
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 50
Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris. 49
IKKalpha downregulation in psoriasis: New insights in the pathway regulating keratinocyte proliferation 49
Programmed cell death in the skin 49
A p38-dependent pathway regulates Delta Np63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes 49
Elementi di dermatologia 49
Adalimumab for severe psoriasis and psoriatic arthritis: an open label study in 30 patients previously treated with other biologics 49
Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX. 48
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 48
Prevalence and genomic variability of transfusion transmitted virus in Italian cryptogenic chronic liver disease and healthy blood donors. 48
RelA/NF-kappaB recruitment on the bax gene promoter antagonizes p73-dependent apoptosis in costimulated T cells 47
Delta Np63 knockdown mice: a mouse model for AEC syndrome 47
Professor Sergio Chimenti: 1949-2016 47
A myogenic differentiation checkpoint activated by genotoxic stress 47
p63 and p73 transactivate differentiation gene promoters in human keratinocytes 47
Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients 47
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target. 46
Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling 46
HLA-C*06 and response to ustekinumab in Caucasian patients with psoriasis: Outcome and long-term follow-up 46
Long-term safety of etanercept in psoriasis: Retrospective study focused on infections 46
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis 46
Two new p73 splice variants, gamma and delta, with different transcriptional activity 45
Role of the HLA-C(star)06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients 45
Different applications of monochromatic excimer light in skin diseases 45
HLACw6 predisposes to clinical response to IL12/23 blocker ustekinumab: Results of short- and long-term treatment in anti-TNF naive patients 45
A role of p73 in mitotic exit 45
No metagenomic evidence of tumorigenic viruses in cancers from a selected cohort of immunosuppressed subjects 45
Structure, function and regulation of p63 and p73. . 1999 Dec;6(12):1146-53 45
Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope 45
“Wide band reflectance spectral microscope and related spectral image method” 45
Living Matter Observations with a Novel Hyperspectral Supercontinuum Confocal Microscope for VIS to Near-IR Reflectance Spectroscopy 44
The p73 gene is an anti-tumoral target of the RAR beta/gamma-selective retinoid tazarotene 44
c-E10 is a caspase-recruiting domain-containing protein that interacts with components of death receptors signaling pathway and activates nuclear factor-kappaB 44
DNp73 alpha protects myogenic cells from apoptosis. 44
Infection of circulating and liver infiltrating T cells by hepatitis C virus of different subtypes. 44
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis. 44
p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis 44
Label-free and non-invasive discrimination of HaCaT and melanoma cells in a co-culture model by hyperspectral confocal reflectance microscopy 44
HLA‐C*06 and psoriasis: susceptibility, phenotype, course and response to treatment 44
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias 44
Anziano e dermatologia 44
Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2. Nuclear factor kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase/stress-activated protein kinase 44
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naive patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial 44
Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis. Gastroenterology. 1997 Oct;113(4):1384-9 44
Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells 43
p63-dependent and independent mechanisms of nectin-1 and -4 regulation in the epidermis. 43
Maturation of intermediate cells into spinous cells during skin development requires induction of IKK alpha by Delta Np63 alpha 43
Adenosine deaminase, a key enzyme in DNA precursors control, is a new p73 target 43
Patient-relevant needs and treatment goals in nail psoriasis. 43
Induction of gene expression via activator protein-1 in the ascorbate protection against UV-induced damage. 43
Dermatophytosis Caused by Trichophyton verrucosum in an Immunosuppressed Patient: Successful Outcome with Terbinafine 43
Nuclear factor kB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2 43
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA. 43
Vav cooperates with CD28 to induce NF-kappa B activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1 43
Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides. 43
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 43
TRIM8 and p53: making the right decision. 42
DLX5, FGF8 and the Pin1 isomerase control ΔNp63α protein stability during limb development: a regulatory loop at the basis of the SHFM and EEC congenital malformations. 42
Totale 5.287
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.050
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 0 0 7
2020/20212.668 25 84 31 14 23 803 361 188 504 358 3 274
2021/20221.472 49 12 19 323 21 38 57 195 143 111 413 91
2022/20234.235 595 166 374 543 399 390 5 353 790 319 242 59
2023/20242.627 158 237 592 68 54 222 174 416 44 54 211 397
2024/202585 85 0 0 0 0 0 0 0 0 0 0 0
Totale 11.094